EAACI celebrates 60 years of influencing policy and medical practice in Europe and beyond
The European Academy of Allergy and Clinical Immunology (EAACI) celebrates today in Florence 60 years of successful acti…
The European Academy of Allergy and Clinical Immunology (EAACI) celebrates today in Florence 60 years of successful acti…
Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that a one-year Phase 3 study, known as LIBER…
Despite the currency crisis and a difficult economic environment, the Galenica Group contin-ued to grow in 2011 and gene…
The potential for improving the quality of life is the most important property of any hay fever medication for those aff…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced results from a Phase III study of QNAZETM (beclometha…
Sneezing and itching, congestion and a constantly runny nose along with watery, red and swollen eyes - especially in win…
Spring is in the air at last! Most of us look forward to the end of the cold dark winter months and all the delights of…
The long, cold winter is finally over! The days are getting longer, the weather is getting warmer, the grass is getting…
. - Sepracor acquires exclusive development, marketing and commercialisation rights to the Ciclesonide franchise in the…
Nycomed announced today that the Food and Drug Administration (FDA) approved ALVESCO® (ciclesonide) Inhalation Aerosol i…